3rd Quarter - Report

THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act S.527, Prescription Pricing for the People Act H.R.2450, Prescription Drug Transparency and Affordability Act S.882, Patients Before Middlemen Act S.526, Pharmacy Benefit Manager Transparency Act

LobbyistCovered position, as disclosed
PAULA GUTIERREZ —
ALEXANDER ROOT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 526 (119th), H.R. 2450 (119th), S. 932 (119th), H.R. 1262 (119th), H.R. 1414 (119th), H.R. 1492 (119th), H.R. 946 (119th), S. 882 (119th), S. 527 (119th), S. 832 (119th), H.R. 1509 (119th), S. 752 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.